ATANIS Biotech AG completes Financing Round
ATANIS Biotech AG, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase.
Intel Capital invests in UNISERS AG
Intel Capital, a leading investor in the future of compute, has invested in UNISERS AG, a Swiss semiconductor metrology company that identifies invisible contamination-caused defects in semiconductor materials. The USD14m seed financing round was led by Intel Capital, with participation from M Ventures, RSBG Ventures and Swisscom Ventures.
Bachem raises CHF 108.1m to accelerate its growth plans
Bachem Holding AG (SIX:BANB) has raised a total of CHF 108.1 million through an accelerated bookbuilding process by issuing 1,250,000 new shares at a placement price of CHF 86.50 per share to accelerate its growth plans.
Merger of e-Xpert Solutions and One Step Beyond
The Geneva-based cybersecurity firm e-Xpert Solutions SA and the Vaud-based One Step Beyond Group SA, which both specialized in consulting and cloud integration, have merged under a new structure called Swiss Expert Group.
BlackSheep MadTech Fund invests in Nexoya AG
BlackSheep MadTech Fund, managed by EUREKA! Venture SGR, the first European venture capital fund with an entrepreneurial background that invests in the marketing and advertising technology industry, has been the lead investor in the USD 5m series A investment round of Nexoya AG, a Swiss marketing analytics start up.
Huntsman sells Textile Effects Division to Archroma
Huntsman Corporation closed the sale of its Textile Effects division to Archroma on February 28, 2023.
Medartis increases stake in KeriMedical
Medartis (SIX: MED), a Basel-based orthopedic company specializing in head and extremity surgery, recently signed an agreement with the private founders of KeriMedical, a Geneva-based private company specializing in the development and manufacture of implants for hand and wrist surgery, to acquire an additional 18% stake for a purchase price of approximately CHF 18m.
Fangda Carbon New Material Co., Ltd. completes GDR Offering and Listing on SIX Swiss Exchange
Fangda Carbon New Material Co., Ltd., an integrated carbon materials producer in in the People's Republic of China with diversified product offerings, including graphite electrodes, carbon blocks, isostatic graphite and iron ore concentrates, sold 22m global depositary receipts (GDRs) at an offer price of USD 8.63 per GDR and listed on 15 March 2023 a total number of 57'089'555 GDRs on the SIX Swiss Exchange (ISIN: US30712D1072, ticker: FDCB), thereby successfully tapping the Swiss capital market and raising gross proceeds of approximately USD 190m. Each GDR represents ten A shares of Fangda, which in turn are listed on the Shanghai Stock Exchange (600516.SH).
CODE41 issuer of tokenized securities
CODE41 SA, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus SA and the opensource smart contract published by CMTA.
Oculis to list on NASDAQ
Oculis Holding AG ("Oculis") a global biopharmaceutical company purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”).